The Global Systemic Lupus Erythematosus Treatment Market is valued approximately at USD 2.95 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 8.64% over the forecast ...
ADI-001 clinical development program now addresses six autoimmune diseases. Patient enrollment for idiopathic inflammatory myopathy and stiff person syndrome cohort expected to be ...